This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.
All patients undergoing FNA for thyroid nodule diagnosis.
Any race and ethnicity are eligible for the study.
Patient should have thyroid nodule(s) with indeterminate diagnosis after FNA (Bethesda category of indeterminate FNA [III-V]).
None
City of Hope Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator